Login
$SORA
$2.28 -$0.02 (0.87%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Dec 31, 2025
Q4 FY2024
As of Dec 31, 2024
Current Assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Inventories, net
Investment in equity securities, current
Amount due from a related party
Loans receivable, net
Prepaid expenses, current
Deposits and other current assets, net
Total current assets
Property and equipment, net
Digital assets
Investment in equity securities, non-current
Operating lease right-of-use asset, net
Deferred initial public offering (“IPO”) costs
Prepaid expenses, non-current
Deferred tax assets, net
Total assets
Current liabilities
Accounts payable
Bank borrowings, current
Contract liabilities
Accrued expenses and other current liabilities
Total current liabilities
Bank borrowings, non-current
Convertible debts
Total liabilities
Shareholders’ equity
Ordinary shares ($0.0005 par value, 100,000,000 shares authorized; 24,864,000 and 22,200,000 shares issued and outstanding as of December 31, 2025 and 2024)
Additional paid-in capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive (loss) income
Total shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support